# A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

> **NCT04467060** · PHASE1 · COMPLETED · sponsor: **Sihuan Pharmaceutical Holdings Group Ltd.** · enrollment: 74 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Anaprazole Sodium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04467060
- **Lead sponsor:** Sihuan Pharmaceutical Holdings Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-14
- **Primary completion:** 2015-06-25
- **Final completion:** 2015-06-25
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467060, "A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04467060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*